| Apical sodium dependent bile acid transporter (ASBT, SLC10A2): a potential prodrug target. | |
MedLine Citation:
|
PMID: 16749855 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A major hurdle impeding the successful clinical development of drug candidates can be poor intestinal permeability. Low intestinal permeability may be enhanced by a prodrug approach targeting membrane transporters in the small intestine. Transporter specificity, affinity, and capacity are three factors in targeted prodrug design. The human apical sodium dependent bile acid transporter (SLC10A2) belongs to the solute carrier family (SLC) of transporters and is an important carrier protein expressed in the small intestine. In spite of its appearing to be an excellent target for prodrug design, few studies have targeted human apical sodium dependent bile acid transporter (hASBT) to improve oral bioavailability. This review discusses bile acids including their chemistry and their absorptive disposition. Additionally, hASBT-mediated prodrug targeting is discussed, including QSAR, in vitro models for hASBT assay, and the current progress in utilizing hASBT as a drug delivery target. |
Authors:
|
Anand Balakrishnan; James E Polli |
Related Documents
:
|
17478525 - Fatty acid binding protein facilitates sarcolemmal fatty acid transport but not mitocho... 9044165 - Tubular transport mechanisms of quinapril and quinaprilat in the isolated perfused rat ... 20448275 - Development and validation of a high-throughput screening assay for human long-chain fa... 8963675 - The basic amino acid transporter (rbat)-like immunoreactivity in paraventricular and su... 15000465 - Use of an 8(1)3(2) asymmetrical factorial design for the in vitro evaluation of ondanse... 3110145 - Acetylcholine stimulates selective liberation and re-esterification of arachidonate and... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Review |
Journal Detail:
|
Title: Molecular pharmaceutics Volume: 3 ISSN: 1543-8384 ISO Abbreviation: Mol. Pharm. Publication Date: 2006 May-Jun |
Date Detail:
|
Created Date: 2006-06-05 Completed Date: 2006-08-08 Revised Date: 2010-09-14 |
Medline Journal Info:
|
Nlm Unique ID: 101197791 Medline TA: Mol Pharm Country: United States |
Other Details:
|
Languages: eng Pagination: 223-30 Citation Subset: IM |
Affiliation:
|
Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Oral Animals Bile Acids and Salts / chemistry, metabolism* Biological Availability Biological Transport Cell Line Drug Delivery Systems* Enterohepatic Circulation Humans Organic Anion Transporters, Sodium-Dependent / metabolism* Prodrugs / metabolism* Quantitative Structure-Activity Relationship Symporters / metabolism* |
| Grant Support | |
ID/Acronym/Agency:
|
DK67530/DK/NIDDK NIH HHS; R01 DK067530-02/DK/NIDDK NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Bile Acids and Salts; 0/Organic Anion Transporters, Sodium-Dependent; 0/Prodrugs; 0/Symporters; 145420-23-1/sodium-bile acid cotransporter |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Coordinate regulation of hepatic bile acid oxidation and conjugation by nuclear receptors.
Next Document: Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and t...